uracil has been researched along with Abnormality, Heart in 1 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pysz, P | 1 |
| Rajtar-Salwa, R | 1 |
| Smolka, G | 1 |
| Olivotto, I | 1 |
| Wojakowski, W | 1 |
| Petkow-Dimitrow, P | 1 |
1 trial available for uracil and Abnormality, Heart
| Article | Year |
|---|---|
Mavacamten - a new disease-specific option for pharmacological treatment of symptomatic patients with hypertrophic cardiomyopathy.
Topics: Benzylamines; Cardiomyopathy, Hypertrophic; Heart Defects, Congenital; Humans; Uracil; Ventricular O | 2021 |